B&C Group (Belgium)   Report issue

For profit Phase 1
Founded: Mont-Saint-Guibert Belgium (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2016
NCT03038230
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

mcla-117 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1